- Report
- January 2026
- 197 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 218 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 271 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 276 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 126 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 93 Pages
Global
From €4983EUR$5,600USD£4,327GBP
- Report
- January 2026
- 270 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 279 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 278 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 238 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 95 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 377 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 285 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 280 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 196 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 381 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 280 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 266 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 286 Pages
Global
From €5206EUR$5,850USD£4,520GBP
- Report
- January 2026
- 186 Pages
Global
From €5206EUR$5,850USD£4,520GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more